A prospective, multicenter, open label, phase IV study to evaluate safety and efficacy of Adapalene 0.3% - Benzoyl peroxide 2.5% gel in subjects with Moderate to Severe Acne Vulgaris.
An Prospective,open label,multicentric, single-arm, non-comparative post marketing clinical study to evaluate effectiveness and safety of Restylane® Lidocaine in subjects undergoing treatment for facial wrinkles and lip augmentation and Restylane® Perlane Lidocaine in subjects undergoing treatment for facial folds and volume loss
Evaluation of â??Quality of Lifeâ?? and in-use tolerance in women with facial melasma, after using a triple combination drug (TRI-LUMA Cream)
100 Clinical Results associated with Galderma India Pvt Ltd.
0 Patents (Medical) associated with Galderma India Pvt Ltd.
100 Deals associated with Galderma India Pvt Ltd.
100 Translational Medicine associated with Galderma India Pvt Ltd.